Literature DB >> 31996019

Interleukin-1 Beta-Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment.

Rebecca A Porritt1, Janet L Markman1, Daisuke Maruyama1, Begum Kocaturk1, Shuang Chen1,2,3,4, Thomas J A Lehman5, Youngho Lee1, Michael C Fishbein4, Magali Noval Rivas1,2,3,4, Moshe Arditi1,2,3,4.   

Abstract

OBJECTIVE: Kawasaki disease (KD) is the leading cause of acute vasculitis and acquired heart disease in children in developed countries. Notably, KD is more prevalent in males than females. We previously established a key role for IL (interleukin)-1 signaling in KD pathogenesis, but whether this pathway underlies the sex-based difference in susceptibility is unknown. Approach and
Results: The role of IL-1 signaling was investigated in the Lactobacillus casei cell wall extract-induced experimental mouse model of KD vasculitis. Five-week-old male and female mice were injected intraperitoneally with PBS, Lactobacillus caseicell wall extract, or a combination of Lactobacillus caseicell wall extract and the IL-1 receptor antagonist Anakinra. Aortitis, coronary arteritis inflammation score and abdominal aorta dilatation, and aneurysm development were assessed. mRNA-seq (messenger RNA sequencing) analysis was performed on abdominal aorta tissue. Publicly available human transcriptomics data from patients with KD was analyzed to identify sex differences and disease-associated genes. Male mice displayed enhanced aortitis and coronary arteritis as well as increased incidence and severity of abdominal aorta dilatation and aneurysm, recapitulating the increased incidence in males that is observed in human KD. Gene expression data from patients with KD and abdominal aorta tissue of Lactobacillus caseicell wall extract-injected mice showed enhanced Il1b expression and IL-1 signaling genes in males. Although the more severe IL-1β-mediated disease phenotype observed in male mice was ameliorated by Anakinra treatment, the milder disease phenotype in female mice failed to respond.
CONCLUSIONS: IL-1β may play a central role in mediating sex-based differences in KD, with important implications for the use of anti-IL-1β therapies to treat male and female patients with KD.

Entities:  

Keywords:  IL-1; aneurysm; arteritis; bacterial cell wall extract; inflammation; vasculitis

Mesh:

Substances:

Year:  2020        PMID: 31996019      PMCID: PMC7047651          DOI: 10.1161/ATVBAHA.119.313863

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  63 in total

1.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

2.  Incidence of Kawasaki disease in northern European countries.

Authors:  Eeva Salo; Elizabeth P Griffiths; Teresa Farstad; Bodil Schiller; Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Brookie M Best; Jane C Burns
Journal:  Pediatr Int       Date:  2012-10-08       Impact factor: 1.524

Review 3.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

4.  Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : The Tromsø Study.

Authors:  K Singh; K H Bønaa; B K Jacobsen; L Bjørk; S Solberg
Journal:  Am J Epidemiol       Date:  2001-08-01       Impact factor: 4.897

5.  Circulating interleukin-1 beta in patients with Kawasaki disease.

Authors:  C P Maury; E Salo; P Pelkonen
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

6.  Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.

Authors:  Ho-Chang Kuo; Jen-Chieh Chang; Hsing-Chun Kuo; Hong-Ren Yu; Chih-Lu Wang; Chiu-Ping Lee; Li-Tong Huang; Kuender D Yang
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

7.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

8.  Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.

Authors:  Preeti Jaggi; Asuncion Mejias; Zhaohui Xu; Han Yin; Melissa Moore-Clingenpeel; Bennett Smith; Jane C Burns; Adriana H Tremoulet; Alejandro Jordan-Villegas; Damien Chaussabel; Karen Texter; Virginia Pascual; Octavio Ramilo
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

9.  IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.

Authors:  M Gorelik; Y Lee; M Abe; T Andrews; L Davis; J Patterson; S Chen; T R Crother; G J Aune; M Noval Rivas; M Arditi
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

10.  Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease.

Authors:  Young-Chang Kwon; Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung-Ki Han; Min Seob Song; Hyoung Doo Lee; Kee-Soo Ha; Sejung Sohn; Ryota Ebata; Hiromichi Hamada; Hiroyuki Suzuki; Kaoru Ito; Yoshihiro Onouchi; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more
  9 in total

1.  NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis.

Authors:  Rebecca A Porritt; David Zemmour; Masanori Abe; Moshe Arditi; Magali Noval Rivas; Youngho Lee; Meena Narayanan; Thacyana T Carvalho; Angela C Gomez; Daisy Martinon; Chintda Santiskulvong; Michael C Fishbein; Shuang Chen; Timothy R Crother; Kenichi Shimada
Journal:  Circ Res       Date:  2021-09-14       Impact factor: 23.213

2.  Exploration of Potential Biomarker Genes and Pathways in Kawasaki Disease: An Integrated in-Silico Approach.

Authors:  Priyanka Srivastava; Chitra Bamba; Rakesh Kumar Pilania; Anu Kumari; Rajni Kumrah; Archan Sil; Surjit Singh
Journal:  Front Genet       Date:  2022-05-09       Impact factor: 4.772

Review 3.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

4.  Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis.

Authors:  Rebecca A Porritt; Carol Chase Huizar; Edward J Dick; Shyamesh Kumar; Renee Escalona; Angela C Gomez; Stefani Marek-Iannucci; Magali Noval Rivas; Jean Patterson; Thomas G Forsthuber; Moshe Arditi; Mark Gorelik
Journal:  Front Immunol       Date:  2021-04-09       Impact factor: 7.561

5.  Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis.

Authors:  Stefanie Marek-Iannucci; Asli B Ozdemir; Debbie Moreira; Angela C Gomez; Malcolm Lane; Rebecca A Porritt; Youngho Lee; Kenichi Shimada; Masanori Abe; Aleksandr Stotland; David Zemmour; Sarah Parker; Elsa Sanchez-Lopez; Jennifer Van Eyk; Roberta A Gottlieb; Michael C Fishbein; Michael Karin; Timothy R Crother; Magali Noval Rivas; Moshe Arditi
Journal:  JCI Insight       Date:  2021-09-22

6.  Targeting IRE1 endoribonuclease activity alleviates cardiovascular lesions in a murine model of Kawasaki disease vasculitis.

Authors:  Stefanie Marek-Iannucci; Asli D Yildirim; Syed M Hamid; Asli B Ozdemir; Angela C Gomez; Begüm Kocatürk; Rebecca A Porritt; Michael C Fishbein; Takao Iwawaki; Magali Noval Rivas; Ebru Erbay; Moshe Arditi
Journal:  JCI Insight       Date:  2022-03-22

7.  Characterization of Inflammatory Factors and T Cell Subpopulations in a Murine Model of Kawasaki Disease Induced by Candida albicans Cell Wall Extracts (CAWS).

Authors:  Huifang Xu; Jing Weng; Quan Bao; Fengyan Nie; Yuqiang Jiang; Cong Xiao
Journal:  Med Sci Monit       Date:  2022-05-07

8.  Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.

Authors:  Hao Zhang; Hao-Bin Song; De-Xing Wang; Hong-Yu Deng; Wen-Long Sun
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

9.  An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.

Authors:  Christoph Kessel; Isabelle Koné-Paut; Stéphanie Tellier; Alexandre Belot; Katja Masjosthusmann; Helmut Wittkowski; Sabrina Fuehner; Linda Rossi-Semerano; Perrine Dusser; Isabelle Marie; Nadja Boukhedouni; Helène Agostini; Céline Piedvache; Dirk Foell
Journal:  J Clin Immunol       Date:  2022-06-14       Impact factor: 8.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.